Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Social connection enhancement" is not the name of a specific molecule, receptor, or druggable biological target. Rather, it is a descriptive outcome or goal referring to the augmentation of interpersonal connection, trust, empathy, and social bonding. In biomedical and neuroscience research, social connection is considered a critical factor in health and well-being[7][9], but it is not itself a molecular entity. There are molecular systems and receptors involved in facilitating social connection, most notably oxytocin and its receptor, as well as dopamine pathways[2][3][4][6][8][10]. Oxytocin, often called the "love hormone", is the most well-studied molecular target involved in social bonding, trust, and affiliative behaviors, but "social connection enhancement" does not refer to any one protein, gene, or receptor—it is instead a higher-order behavioral and psychological construct[1][2][4]. Attempts to enhance social connection pharmacologically typically target the oxytocin system or related neurochemical pathways, but the phrase as presented cannot be mapped to a specific canonical biological target[2][4][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Social connection enhancement.